- Report
- November 2025
- 135 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- October 2025
- 80 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- October 2025
- 89 Pages
Global
From €4287EUR$4,850USD£3,715GBP
- Report
- August 2025
- 115 Pages
Global
From €3050EUR$3,450USD£2,642GBP
- Report
- June 2025
- 193 Pages
Global
From €4375EUR$4,950USD£3,791GBP
- Report
- June 2025
- 105 Pages
Global
From €3050EUR$3,450USD£2,642GBP
- Report
- June 2025
- 180 Pages
Global
From €3536EUR$4,000USD£3,064GBP
- Report
- April 2026
Middle East, Africa
From €4242EUR$4,799USD£3,676GBP
- Report
- August 2025
- 200 Pages
United States
From €2201EUR$2,490USD£1,907GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5259EUR$5,950USD£4,557GBP
- Report
- September 2025
- 150 Pages
Middle East
From €4375EUR$4,950USD£3,791GBP
- Report
- September 2025
- 150 Pages
United States
From €5259EUR$5,950USD£4,557GBP
- Report
- September 2025
- 85 Pages
United States
From €3094EUR$3,500USD£2,681GBP
- Report
- May 2025
- 85 Pages
United States
From €3094EUR$3,500USD£2,681GBP
- Report
- October 2025
- 87 Pages
United States
From €4287EUR$4,850USD£3,715GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4287EUR$4,850USD£3,715GBP
- Report
- August 2025
- 80 Pages
Middle East, Africa
From €3050EUR$3,450USD£2,642GBP
- Report
- August 2025
- 98 Pages
Asia Pacific
From €3491EUR$3,950USD£3,025GBP
- Report
- August 2025
- 101 Pages
Europe
From €3491EUR$3,950USD£3,025GBP
- Report
- August 2025
- 90 Pages
North America
From €3050EUR$3,450USD£2,642GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more